HB 8: Require health plan and Medicaid coverage of biomarker testing
This bill requires health benefit plans to cover biomarker testing for diagnosis, treatment, and ongoing monitoring of diseases or conditions. Biomarker testing is defined as the analysis of tissue, blood, or other biospecimens to identify specific characteristics that can help diagnose or treat diseases. The bill also requires Medicaid to cover biomarker testing when it is deemed medically necessary by a qualified healthcare provider and supported by medical or scientific evidence. The bill aims to ensure coverage for appropriate biomarker testing to produce long-term healthcare cost savings and improve health outcomes for Ohioans. However, it does not intend to create a landscape that would allow manufacturers and administrators of biomarker tests to substantially increase pricing for existing and new biomarker tests. The bill ensures that coverage for biomarker testing is made readil…
| Feb. 18, 2026 | Reported - Amended: Health |
| Jan. 28, 2025 | Referred to committee: Health |
| Jan. 23, 2025 | Introduced |